Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 6.3.2017 | EN | Official Journal of the European Union | C 70/31 |

---

Action brought on 23 January 2017 — Forest Pharma v EUIPO — Ipsen Pharma (COLINEB)

(Case T-36/17)

(2017/C 070/40)

Language in which the application was lodged: English

Parties

Applicant: Forest Pharma BV (Amsterdam, Netherlands) (represented by: T. Holman, Solicitor)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Ipsen Pharma SAS (Boulogne Billancourt, France)

Details of the proceedings before EUIPO

Applicant: Applicant

Trade mark at issue: EU word mark ‘COLINEB’ — Application for registration No 13 191 671

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 13 October 2016 in Case R 500/2016-5

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | order EUIPO to pay the costs. |

Plea in law

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) of Regulation No 207/2009. |

---

[Top](#document1)